This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Roche Molecular Systems, Inc.. Active years: 2018-2021.
Company Filing History:
Years Active: 2018-2021
Title: Innovations of Andy Yuen in Drug Resistance Detection
Introduction
Andy Yuen is an accomplished inventor based in Dublin, CA (US). He has made significant contributions to the field of molecular diagnostics, particularly in the detection of drug-resistant tuberculosis. With a total of 2 patents, his work has the potential to impact public health positively.
Latest Patents
Yuen's latest patents focus on compositions and methods for the rapid detection of drug-resistant Mycobacterium tuberculosis (MTB). These methods include steps for amplifying, hybridizing, and detecting the presence or absence of MTB resistant to rifampicin (MTB-RIF) and isoniazid (MTB-INH) in various samples. His patents also provide primers and probes targeting the genes for rpoB, inhA, and katG, along with kits designed for effective detection of these resistant strains.
Career Highlights
Throughout his career, Andy Yuen has worked with notable companies such as Roche Molecular Systems, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop innovative solutions in the field of molecular diagnostics.
Collaborations
Yuen has collaborated with professionals like Jenny A Johnson and Rochak Mehta, contributing to advancements in his field.
Conclusion
Andy Yuen's innovative work in drug resistance detection showcases his commitment to improving healthcare through technology. His patents and collaborations reflect a dedication to addressing critical health challenges.